ATE52543T1 - Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus. - Google Patents

Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.

Info

Publication number
ATE52543T1
ATE52543T1 AT85850190T AT85850190T ATE52543T1 AT E52543 T1 ATE52543 T1 AT E52543T1 AT 85850190 T AT85850190 T AT 85850190T AT 85850190 T AT85850190 T AT 85850190T AT E52543 T1 ATE52543 T1 AT E52543T1
Authority
AT
Austria
Prior art keywords
cell surface
surface protein
fibrinogen
collagen
fibronectin
Prior art date
Application number
AT85850190T
Other languages
English (en)
Inventor
Magnus Hoeoek
Kjell Martin Lindberg
Torkel Mikael Wadstroem
Original Assignee
Alfa Laval Agri Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Laval Agri Int filed Critical Alfa Laval Agri Int
Application granted granted Critical
Publication of ATE52543T1 publication Critical patent/ATE52543T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
AT85850190T 1984-05-30 1985-05-30 Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus. ATE52543T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel
EP85850190A EP0163623B1 (de) 1984-05-30 1985-05-30 Verwendung eines Zelloberflächenprotein gewonnen aus Staph. aureus

Publications (1)

Publication Number Publication Date
ATE52543T1 true ATE52543T1 (de) 1990-05-15

Family

ID=20356083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85850190T ATE52543T1 (de) 1984-05-30 1985-05-30 Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.

Country Status (13)

Country Link
EP (1) EP0163623B1 (de)
JP (1) JPH0747541B2 (de)
AT (1) ATE52543T1 (de)
AU (1) AU600886B2 (de)
CA (1) CA1340401C (de)
DE (1) DE3577579D1 (de)
ES (1) ES8900019A1 (de)
FI (1) FI84431C (de)
IE (1) IE59203B1 (de)
NO (1) NO164992C (de)
NZ (1) NZ212244A (de)
SE (1) SE454403B (de)
WO (1) WO1985005553A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702272L (sv) * 1987-06-01 1988-12-02 Alfa Laval Agri Int Fibronektinbindande protein samt dess framstaellning
SE8801723D0 (sv) * 1988-05-06 1988-05-06 Staffan Normark Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
SE9003374D0 (sv) * 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
EP0621875B1 (de) * 1992-09-21 2002-03-27 Alfa-Laval Agri International Ab Fibrinogen-bildungsprotein
JPH0840932A (ja) 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
GB9415902D0 (en) * 1994-08-05 1994-09-28 Smithkline Beecham Plc Method of treatment
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
ES2322409T3 (es) * 1998-08-31 2009-06-19 Inhibitex, Inc. Vacunas multicomponentes contra staphylococcus aureus.
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
CA2517439C (en) 2003-03-07 2013-07-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
EA014352B1 (ru) 2005-08-10 2010-10-29 Арне Форсгрен Аб Взаимодействие moraxella catarrhalis с эпителиальными клетками, внеклеточными матриксными белками и системой комплемента
SA110310528B1 (ar) 2009-06-22 2014-07-02 Wyeth Llc التركيبات المولدة للمناعة لأنتيجينات ستافيلوكوكس أوريس
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
TW201302779A (zh) 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide

Also Published As

Publication number Publication date
SE8402938L (sv) 1985-12-01
EP0163623A3 (en) 1987-02-25
JPS61502334A (ja) 1986-10-16
IE851337L (en) 1985-11-30
FI860417L (fi) 1986-01-29
EP0163623B1 (de) 1990-05-09
FI84431B (fi) 1991-08-30
NO860321L (no) 1986-01-29
FI84431C (fi) 1991-12-10
JPH0747541B2 (ja) 1995-05-24
DE3577579D1 (de) 1990-06-13
FI860417A0 (fi) 1986-01-29
EP0163623A2 (de) 1985-12-04
SE454403B (sv) 1988-05-02
NO164992B (no) 1990-08-27
ES543635A0 (es) 1988-11-01
IE59203B1 (en) 1994-01-26
ES8900019A1 (es) 1988-11-01
CA1340401C (en) 1999-02-23
SE8402938D0 (sv) 1984-05-30
AU600886B2 (en) 1990-08-30
WO1985005553A1 (en) 1985-12-19
NO164992C (no) 1990-12-05
NZ212244A (en) 1989-03-29

Similar Documents

Publication Publication Date Title
ATE52543T1 (de) Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.
ATE7201T1 (de) Verfahren zur herstellung eines bakteriellen praeparates zur verhuetung von darmbeschwerden beim gefluegel.
ATE51024T1 (de) Freisetzung von produkten von bakterien.
DE3280150D1 (de) Mikroorganismen fuer den mikrobiellen abbau von schaedlichen organischen abfallstoffen in unschaedliche materialien.
ATE456648T1 (de) Verfahren zur herstellung von l-aminosäure
ES505525A0 (es) Procedimiento industrial de cultivo de microorganismos tales como bacterias y hongos.
SE8803071L (sv) Bakteriebehandling foer att bevara hoekvalitet genom att tillaegga genius bacillus mikroorganismer
DE59003144D1 (de) Destillationsanlage zur Herstellung von Wasserstoff-Peroxid.
DE3789428D1 (de) Mikroorganismen, fähig zur Laktoseassimilation.
ATE30049T1 (de) Verfahren zur herstellung von d-milchsaeure unter verwendung von lactobacillus bulgaricus dsm 2129.
BR8702649A (pt) Composicao biocida,processo para inibicao do crescimento de microorganismos,meio,couro ou madeira,composto e complexo ferrico
AU3180184A (en) Method of expressing alpha-1-antitrypsin in bacteria
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
ATE128814T1 (de) Käseherstellungsverfahren.
ATE7309T1 (de) Verfahren zur herstellung von d-n-carbamoyl-alpha-aminosaeuren und mikroorganismen dafuer.
SE8104840L (sv) Framstellning av endoproteinas
DE58907274D1 (de) VERFAHREN ZUR STEIGERUNG VON ENZYM-AKTIVITÄTEN UND DER SYNTHESELEISTUNG VON MIKROORGANISMEN UND HöHEREN PFLANZEN.
FR2429765A1 (fr) Procede et agent d'adsorption pour isoler des enzymes et pour les preparer a l'etat pur
ATE66343T1 (de) Behandlungsverfahren fuer milch zur erhaltung von kaese.
ATE95188T1 (de) Zellulaere amphipatische proteine in aggregierten formen und verfahren zur herstellung und reinigung diese proteine.
DE3884922D1 (de) Verfahren zur Herstellung von thermostabilen alpha-Amylasen durch Kultivierung von überproduzierenden Mikroorganismen.
DK143984A (da) Nitrogenkilde til organismer
DE3885380D1 (de) Verfahren zur Herstellung von modifiziertem, ferromagnetischem Chromdioxid.
ATE23189T1 (de) Verfahren zur herstellung von sphaerischen zellaggregaten von mikroorganismen.
ATE17372T1 (de) Verfahren zur herstellung genetisch modifizierter mikroorganismen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time